Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Study of proinflammatory and anti-inflammatory states in myelodysplastic syndrome patients

The Egyptian Journal of Internal Medicine volume 31, pages 733–740 (2019)Cite this article

Abstract

Background

The myelodysplastic syndrome (MDS) are a group of clonal bone marrow neoplasms characterized by ineffective hematopoiesis, manifested by morphologic dysplasia in hematopoietic cells and by peripheral cytopenia(s) although previous studies have shown cytogenetic and molecular abnormalities, the underlying defect in the molecular pathway for inflammation milieu, extensive apoptosis, and dysplasia observed in the disease is yet to be studied.

Aim of the work

The aim of this study was to show the proinflammatory [tumor necrosis factor-α (TNF-α)/anti-inflammatory [interleukin-10 (IL-10)] balance in different subclassifications of MDS.

Patients and methods

From September 2017 through September 2018, serum levels were measured in 49 patients for TNF-α, IL-10 in patients diagnosed as having MDS. Also, these inflammatory cytokines had been measured in 46 apparently healthy participants as matched controls for the study. The diagnosis of MDS was confirmed by a hematopathologist after review of bone marrow aspiration and/or peripheral blood samples. Conventional cytogenetic studies were performed on bone marrow aspirate material using standard G-banding techniques. These patients were then subclassified according to the revised 2016 WHO classification for MDS.

Results

There is a statically significant difference between MDS patients and control group according to the results of serum level of TNF-α and IL-10. They were higher in MDS patients. Also, there was a statically significant difference between the subclassified groups of MDS patients according the results of serum level of TNF-α and IL-10. TNF-α was higher in MDS with multilineage dysplasia and MDS unclassifiable than the others. Also, IL-10 was higher in MDS with excess blasts 1 and MDS with excess blasts 2 than the others.

Conclusion

TNF-α and IL-10 are increased in MDS patients indicating an inflammatory disturbance. TNF-α and IL-10 serum level are inversely related to each other in the different subclasses of MDS.

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau M, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127:2391–2405.

    Article  CAS  Google Scholar 

  2. Verburgh E, Achten R, Louw VJ, Brusselmans C, Delforge M, Boogaerts M, et al. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. Leukemia 2007; 21:668–677.

    Article  CAS  Google Scholar 

  3. Germing U, Strupp C, Giagounidis A, Haas R, Gattermann N, Starke C, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. Leuk Res 2012; 36:727–734.

    Article  Google Scholar 

  4. Maassen A, Strupp C, Giagounidis A, Kuendgen A, Nachtkamp K, Hildebrandt B, et al. Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts. Leuk Res 2013; 37:64–70.

    Article  Google Scholar 

  5. Frietsch JJ, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, et al. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. Eur J Haematol 2014; 93:247–259.

    Article  CAS  Google Scholar 

  6. Schanz J, Tüchler H, Solé F, Mallo M, Luño E, Cervera J, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 2012; 30:820–829.

    Article  Google Scholar 

  7. Wolach O, Stone R. Autoimmunity and inflammation in myelodysplastic syndromes. Acta Haematol 2016; 136:108–117.

    Article  CAS  Google Scholar 

  8. Wilson AB, Neogi T, Prout M, Jick S. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the general practice research database. Cancer Epidemiol 2014; 38:544–549.

    Article  Google Scholar 

  9. Braun T, Fenaux P. Myelodysplastic syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol 2013; 26:327–336.

    Article  CAS  Google Scholar 

  10. Serio B, Selleri C, Maciejewski JP. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem 2011; 11:544–552.

    Article  CAS  Google Scholar 

  11. Kordasti SY, Ingram W, Hayden J, Darling D, Barber L, Afzali B, et al. CD4 +CD25 high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 2007; 110:847–850.

    Article  CAS  Google Scholar 

  12. Kittang A, Kordasti S, Sand KE, Costantini B, Kramer AM, Perezabellan P, et al. Expansion of myeloid derived suppressor cells correlates with number of t regulatory cells and disease progression in myelodysplastic syndrome. Oncoimmunology 2016; 5:e1062208.

    Article  Google Scholar 

  13. Verfaillie CM. Adhesion receptors as regulators of the hematopoietic process. Blood 1998; 92:2609–2612.

    Article  CAS  Google Scholar 

  14. Kornblau SM, Cohen AC, Soper D, Huang YW, Cesano A. Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk mds. Cytom B Clin Cytom 2014; 86:383–396.

    Article  Google Scholar 

  15. Kittang AO, Sand K, Brenner AK, Rye KP, Bruserud Ø. The systemic profile of soluble immune mediators in patients with myelodysplastic syndromes. Int J Mol Sci 2016; 17:1080–1094.

    Article  Google Scholar 

  16. Kasamatsu T, Saitoh T, Minato Y, Shimizu H, Yokohama A, Tsukamoto N, et al. Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndrome. Eur J Haematol 2016; 96:245–251.

    Article  CAS  Google Scholar 

  17. Hatfield KJ, Reikvam H, Bruserud O. The crosstalk between the matrix metalloprotease system and the chemokine network in acute myeloid leukemia. Curr Med Chem 2010; 17:4448–4461.

    Article  CAS  Google Scholar 

  18. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, et al. A paradigm shift in myelodysplastic syndromes. Leukemia 1996; 10:1648–1652.

    CAS  PubMed  Google Scholar 

  19. Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica 2011; 96:602–606.

    Article  CAS  Google Scholar 

  20. Kim HO, Kim HS, Youn JC, Shin EC, Park S. Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med 2011; 9:113.

    Article  CAS  Google Scholar 

  21. Molnár L, Berki T, Hussain A, Németh P, Losonczy H. The role of TNF-alpha in myelodysplastic syndrome: immunoserologic and immunohistochemical studies. Orv Hetil 2000; 141:1807–1811.

    PubMed  Google Scholar 

  22. Parnes A, Nikiforow S, Berliner N, Vanasse GJ. Single nucleotide polymorphisms in the human TNF gene are associated with anaemia and neutropenia in a cohort of patients with de novo myelodysplastic syndrome. Br J Haematol 2010; 150:700–701.

    Article  Google Scholar 

  23. Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis. Eur J Haematol 2005; 75:485–491.

    Article  CAS  Google Scholar 

  24. Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K, et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21: 331–344.

    Article  CAS  Google Scholar 

  25. Pardanani A, Finke C, Lasho TL, Al-Kali A, Begna KH, Hanson CA, et al. IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia 2012; 26:693–699.

    Article  CAS  Google Scholar 

  26. Feng X, Scheinberg P, Wu CO, Samsel L, Nunez O, Prince C, et al. Circulating cytokine profiles of patients with acquired aplastic anemia and myelodysplastic syndrome. Blood 2008; 112:1038.

    Article  Google Scholar 

  27. Tsimberidou AM, Estey E, Wen S, Pierce S, Kantarjian H, Albitar M, et al. The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes. Cancer 2008; 113:1605–1613.

    Article  Google Scholar 

  28. Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y, et al. Prognostic significance of serum ferritin level at diagnosis in myelodysplastic syndrome. Int J Hematol 2012; 95:527–534.

    Article  CAS  Google Scholar 

  29. Chee CE, Steensma DP, Wu W, Hanson CA, Tefferi A. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. Am J Hematol 2008; 83:611–613.

    Article  CAS  Google Scholar 

  30. Cermak J, Kacirkova P, Mikulenkova D, Michalova K. Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts. Leuk Res 2009; 33:1469–1474.

    Article  Google Scholar 

  31. Park S, Sapena R, Kelaidi C, Vassilieff D, Bordessoule D, Stamatoullas A, et al. Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS. Leuk Res 2011; 35:1530–1533.

    Article  CAS  Google Scholar 

  32. Mattar M, Mohamed S, El Husseiny N. Myelodysplastic syndrome: an Egyptian experience. J Blood Disord Transfus 2012; 3:121.

    Google Scholar 

  33. Valent P, Krieger O, Stauder R, Wimazal F, Nösslinger T, Sperr WR, et al. Iron overload in myelodysplastic syndromes (MDS) diagnosis, management, and response criteria: a proposal of the Austrian MDS platform. Eur J Clin Investig 2008; 38:143–149.

    Article  CAS  Google Scholar 

  34. Anwar N, Arshad A, Nadeem M, Khurram S, Fatima N, Sharif S, et al. Clinicohematological and cytogeneticprofile of myelodysplastic syndromes in Pakistan-compare and contrast. Mol Cytogenet 2017; 10:17.

    Article  Google Scholar 

  35. Gupta R, Rahman Kh, Rahman Kh, Kumari S, Yadav G, Nityanand S. Clinico-pathological spectrum and novel karyotypic findings in myelodysplastic syndrome: experience of Tertiary Care Center in India, Mediterr J Hematol Infect Dis 2017; 9:e2017048.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, National Liver Institute, Menoufia University, Sabry Abu Alam Street, 32513, Shebin El-Kom, Menoufia, Egypt

    Alaa E. Hassan

  2. Department of Community, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt

    Marwa Tahoon

  3. Department of Clinical Pathology, National Liver Institute, Menoufia University, Shebin El-Kom, Egypt

    Hanan Bediera

Authors
  1. Alaa E. Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marwa Tahoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hanan Bediera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alaa E. Hassan.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, A.E., Tahoon, M. & Bediera, H. Study of proinflammatory and anti-inflammatory states in myelodysplastic syndrome patients. Egypt J Intern Med 31, 733–740 (2019). https://doi.org/10.4103/ejim.ejim_37_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_37_19

Keywords